| |
| |
|
| Insider
Information: |
Chu Yu-Waye |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
166,926 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$534,569 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
166,926 |
|
|
| Total
Value |
$534,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fate Therapeutics Inc |
FATE |
Chief Medical Officer |
2023-04-18 |
140,676 |
2021-04-16 |
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-01-18 |
26,250 |
2024-01-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
26,250 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Chief Medical Officer |
• – – |
2023-04-18 |
4 |
S |
$6.52 |
$16,648 |
D/D |
(2,532) |
140,676 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Medical Officer |
• – – |
2023-01-10 |
4 |
S |
$5.24 |
$41,003 |
D/D |
(7,825) |
143,208 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-04-19 |
4 |
S |
$35.37 |
$143,673 |
D/D |
(4,062) |
151,033 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
33,302 |
155,095 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Senior VP Clinical Development |
• – – |
2022-01-11 |
4 |
S |
$48.44 |
$192,340 |
D/D |
(3,965) |
121,793 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Senior VP Clinical Development |
• – – |
2021-12-10 |
4 |
OE |
$16.32 |
$122,400 |
D/D |
7,500 |
133,258 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Senior VP Clinical Development |
• – – |
2021-12-10 |
4 |
AS |
$49.32 |
$385,948 |
D/D |
(7,500) |
125,758 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Senior VP Clinical Development |
• – – |
2021-04-16 |
4 |
S |
$81.80 |
$272,809 |
D/D |
(3,275) |
64,800 |
0 |
% |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
